GIM
MRK icon

Glenmede Investment Management’s Merck MRK Stock Holding History

Glenmede Investment Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$45.3M Sell
539,875
-89,706
-14% -$7.39M 0.22% 89
2025
Q2 		$49.8M Buy
+629,581
New +$50M 0.25% 83

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Glenmede Investment Management's MRK Position: Q3 2025 in Review

Glenmede Investment Management reduced its Merck (MRK) stake by 14% in Q3 2025, selling an estimated $7.39M and leaving 539,875 shares worth $45.3M. The position accounts for 0.22% of the portfolio, ranked #89.

Glenmede Investment Management first reported a position in MRK in Q2 2025 and has held it in 2 quarters since. The position peaked at $49.8M in Q2 2025. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Glenmede Investment Management held 539,875 shares of Merck worth $45.3M as of Q3 2025.
  • Glenmede Investment Management sold 89,706 Merck shares in Q3 2025, an estimated $7.39M.
  • Merck made up 0.22% of Glenmede Investment Management's portfolio in Q3 2025, its #89 holding.
  • Glenmede Investment Management first reported a position in Merck in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's Merck position peaked at $49.8M in Q2 2025.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.